GlassScriptPhysician profile
Terry R Baker
NPI 1568406148
$444.42
in general payments reported to CMS, 2019-2025
13 companies · $54.75 in 2025
The $54.75 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $11.71 · 2021: $16.36 · 2022: $75.06 · 2023: $151 · 2024: $32.58 · 2025: $54.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $85.57 | 2022-2025 | |
| Boston Scientific Corporation | $59.56 | 2023 | Watchman Access System, Watchman Flx |
| Stryker Corporation | $58.76 | 2019-2022 | |
| Carestream Dental, LLC | $42.66 | 2019 | |
| Optinose US, INC. | $36.94 | 2019-2024 | |
| Medtronic, INC. | $33.06 | 2023 | Propel |
| Glaxosmithkline, LLC. | $31.61 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $21.93 | 2019 | |
| Phathom Pharmaceuticals, INC. | $17.53 | 2025 | Voquezna |
| Itamar Medical INC | $16.09 | 2023 | Watchpatone |
| Integra Lifesciences Corporation | $15.48 | 2024 | Acclarent Aera |
| Pfizer INC. | $13.52 | 2023 | |
| Intersect Ent, INC. | $11.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.